Marco Dieci

Career:

He served as CEO at Holostem, Executive Director at the facility of Children Hospital Bambino Gesù in Rome, CEO of Xellbiogene, and Operations Director at MolMed.

Education:

Master’s Degree in Chemistry, University of Parma

Expertise:

25 years of management experience in the life science industry, specifically in clinical operations management, pharma business development and market access. Covering different role such as CEO, Executive Director and Chief Operating Officer for the management of Biotech Products & Advance Therapies Medicinal Products in the fields of Clinical and Operation development and Regulatory Affairs, Technology transfer, scale up & industrialization.